DOCSLIB.ORG

Trauma and Injuries to the Salivary Glands Figure 16.10. (Continued)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

k Trauma and Injuries to the Salivary Glands 421 (e) (f) k k (g) Figure 16.10. (Continued) k k 422 Chapter 16 TRAUMA TO SALIVARY GLAND DUCTS treated non-operatively, 9 (47%) healed without complications. Although seven patients (36.8%) Transection developed salivary fistulas and four (21.4%) devel- As has already been discussed previously in oped sialoceles, these were described as short the sections on fistulas and sialoceles related to term and resolved without the need for surgery parenchymal trauma, conservative management (Lewis and Knottenbelt 1991). Van Sickels (1981), is usually satisfactory except in those cases where divided the parotid duct anatomically into three the injury involves partial or complete transac- sites of injury, based on implications for treatment. tion of the duct. Under these circumstances most Site A is the intra-glandular portion of the duct papers have indicated that resolution is less cer- and ductal injuries in this location are treated as tain and takes longer with active management described previously for parenchymal trauma. Site frequently required. There are studies that support B represents the duct as it overlies the masseter conservative measures in duct injuries and in one muscle and site C is the duct’s course anterior to report, of 19 patients with duct injury confirmed the masseter muscle through the deep tissues of by methylene blue dye injection in a retrograde the cheek into the mouth. Injuries at both these fashion through the Stenson duct who were sites require exploration and direct repair of the k k (a) (b) Figure 16.11. (a) Lateral view of face of patient complaining of gustatory sweating (Frey syndrome). (b) Bottle of iodine solution that is painted on the face and then covered with corn starch. (c) While the patient eats an apple the corn starch is colored blue-black, indicative of gustatory sweating. k k Trauma and Injuries to the Salivary Glands 423 k k (c) Figure 16.11. (Continued) duct if possible. If repair is impossible, creating saline or a small (1 cc) amount of methylene blue a direct fistula into the mouth is the treatment of through the Stenson papilla. Van Sickels (2009) choice for site C injuries (Lazaridou, et al. 2012). cautions against injecting too much dye which can However, in most cases current management stain the tissues and increase the difficulty of the is directed toward primary repair and the clinician dissection. Identification of the proximal end may must therefore have a high level of suspicion for be technically difficult as it can retract into the injuries involving the region of the parotid duct. gland substance. Milking the gland to obtain sali- The classic anatomic surface markings of the vary flow is helpful in these circumstances and the duct are illustrated in Figure 16.12. However, an anesthesiologist must be cautioned preoperatively ultrasound study has shown that 92% of ducts against the use of anti-parasympathetic agents. If were below the classic anatomic surface markings, the proximal and distal ends of the duct are identi- although 93% of the ducts were within 1.5 cm fied and can be coapted, then microsurgical repair of the middle half of a line between the tragus and can be carried out (Hallock 1992) (Figure 16.14). the cheilion (Stringer, et al. 2012). In this study, The use of stents (usually indwelling the mean internal caliber of the duct was 0.6+/− catheters) for 10–14 days to prevent stenosis is 0.2 mm. Confirmatory evidence for transaction is advocated by some and appears a reasonable obtained by cannulating the distal portion of the hypothesis, although no long term studies of duct through the Stenson papilla and observing the these injuries with and without stenting has catheter in the wound (Figure 16.13) or by injecting been published. A technique of using a 4F Foley k k 424 Chapter 16 When the injury is too proximal, the wound is avulsive or the duct cannot be identified, the clinician can either create an intraoral fistula or ligate the proximal duct. A controlled fistula can be created by suturing the proximal duct through the buccinator into the oral cavity if enough length is present, or by placing a catheter or drain from the area of the wound into the mouth and leaving it to fistualize (Figure 16.15). Although tying off the proximal duct to cause eventual atrophy has been proposed (Van Sickels 1981), in the author’s experience this is unpredictable and, even with the use of pressure and antisialogogues, these patients can have considerable swelling and pain. Chemical denervation using botulinum toxin A may be used to achieve a good outcome in these circumstances (Arnaud, et al. 2006). In the case of the submandibular duct tran- section is usually iatrogenic as a result of surgery on the sublingual gland, sialolithotomy from Whar- ton duct, or resection of floor of mouth cancer. In this case sialodochoplasty with repositioning of the duct posteriorly is all that is required. A catheter has been used as a stent (Ord and Lee 1996), fol- lowing reposition of Wharton duct in floor of mouth k cancer; however, now the duct lumen is identified, k one blade of a sharp iris scissors is inserted and a vertical cut through one wall of the duct carried out. The duct is now “fish-tailed” and sutured to Figure 16.12. Surface markings of the parotid duct are a newly created hole in the oral mucosa with 6o shown by a line drawn from the tragus of the ear to bisect nylon sutures. Stenosis and stricture has not been a line drawn from the alar base to the commissure. The a problem with this technique. middle third of this line (arrow) is surface marking of the parotid duct. Stenosis of the Duct When ductal injuries are not surgically repaired embolectomy catheter for identification of the immediately complications, such as fistulas and transaction and then left in place as a stent is sialoceles, may arise and their management has described (Etoz, et al. 2006). When the proximal been discussed. If the duct has not been surgically and distal ends of the duct cannot be coapted due repaired by 72 h conservative or medical therapy to tissue loss, repair using a vein graft has been is recommended (Arnaud, et al. 2006). In the long reported (Heymans, et al. 1999). Steinberg and term stricture of the duct may occur, although Herréra (2005) recommended the use of sialog- most strictures are secondary to inflammatory raphy postoperatively to assess the result of duct or infective conditions. In cases of intra-ductal repair, stating this technique may not always be salivary gland obstruction 22.6% of 642 cases practical or possible in the acute setting. How- were due to strictures, which were more com- ever,wehaveusedsialographyintraoperatively mon in females (Ngu, et al. 2007) (Figure 16.16). (Figure 16.13). A further development in the repair When this occurs at the distal end of the Sten- of ductal injuries has been the utilization of the son duct, excision and diversion of the duct into sialendoscope in some centers, for both repair and the oral cavity may be feasible. When the main followup assessment (Koch, et al. 2013; Kopec,´ duct is involved with strictures, sialendoscopy et al. 2013). may be useful to dilate the strictures using saline k k Trauma and Injuries to the Salivary Glands 425 (a) (b) k k (c) (d) Figure 16.13. (a) Patient with cheek laceration that was primarily sutured now has developed sialocele due to missed duct injury. (b) Wound reopened for re-exploration. The duct is discovered to be transected. Vessel loop around distal end of duct. Lacrimal probe passed from intra-oral through the Stenson duct into the wound (short arrow). (c) After finding the proximal end of the duct by milking the gland the duct is approximated. The duct is cannulated and contrast dye injected for intra-operative sialogram. (d) Fluoroscopic image of intra-operative sialogram with repaired duct (arrow). pressure, balloon dilatation, or the miniforceps five of these patients remained asymptomatic grasper, and even the insertion of a stent to the on followup (Salerno, et al. 2007). If this is un- duct lumen (Nahliel, et al. 2004). Simple balloon successful and the patient continues to have recur- angioplasty was successful in 7/9 patients and rent swelling and sialadenitis, denervation with k k 426 Chapter 16 (a) (b) k k (c) (d) Figure 16.14. (a) A 38-year-old man with a laceration of the right cheek in the operating room in preparation for primary closure and exploration of Stenson duct due to the depth and anatomic location of the laceration. (b) Sterile milk was injected in the distal aspect of Stenson duct that permitted the identification of its laceration. (c) The proximal end of the lacerated Stenson duct is able to be cannulated with a lacrimal probe. (d) The proximal and distal ends of the Stenson duct are primarily closed with 6-0 Prolene sutures with an indwelling catheter in place. (e) The catheter is sutured to the oral mucosa and maintained in place for 2 weeks. (f) The cheek wound is primarily closed in anatomic layers. The location of the laceration is appreciated to exist along the middle third of the line denoting the surface marking of the Stenson duct. Source: Courtesy of Dr. J. Greg Anderson and Dr. Michael Foster, University of Tennessee Medical Center Department of Oral and Maxillofacial Surgery. Reproduced with permission of Dr. Anderson. k k Trauma and Injuries to the Salivary Glands 427 (e) (f) Figure 16.14.
Recommended publications
  • Glossary for Narrative Writing

    Glossary for Narrative Writing

    Periodontal Assessment and Treatment Planning Gingival description Color: o pink o erythematous o cyanotic o racial pigmentation o metallic pigmentation o uniformity Contour: o recession o clefts o enlarged papillae o cratered papillae o blunted papillae o highly rolled o bulbous o knife-edged o scalloped o stippled Consistency: o firm o edematous o hyperplastic o fibrotic Band of gingiva: o amount o quality o location o treatability Bleeding tendency: o sulcus base, lining o gingival margins Suppuration Sinus tract formation Pocket depths Pseudopockets Frena Pain Other pathology Dental Description Defective restorations: o overhangs o open contacts o poor contours Fractured cusps 1 ww.links2success.biz [email protected] 914-303-6464 Caries Deposits: o Type . plaque . calculus . stain . matera alba o Location . supragingival . subgingival o Severity . mild . moderate . severe Wear facets Percussion sensitivity Tooth vitality Attrition, erosion, abrasion Occlusal plane level Occlusion findings Furcations Mobility Fremitus Radiographic findings Film dates Crown:root ratio Amount of bone loss o horizontal; vertical o localized; generalized Root length and shape Overhangs Bulbous crowns Fenestrations Dehiscences Tooth resorption Retained root tips Impacted teeth Root proximities Tilted teeth Radiolucencies/opacities Etiologic factors Local: o plaque o calculus o overhangs 2 ww.links2success.biz [email protected] 914-303-6464 o orthodontic apparatus o open margins o open contacts o improper
  • Diseases of Salivary Glands: Review

    Diseases of Salivary Glands: Review

    ISSN: 1812–1217 Diseases of Salivary Glands: Review Alhan D Al-Moula Department of Dental Basic Science BDS, MSc (Assist Lect) College of Dentistry, University of Mosul اخلﻻضة امخجوًف امفموي تُئة رطبة، حتخوي ػىل طبلة ركِلة من امسائل ثدغى انوؼاب ثغطي امسطوح ادلاخوَة و متﻷ امفراغات تني ااطَة امفموًة و اﻷس نان. انوؼاب سائل مؼلد، ًنذج من امغدد انوؼاتَة، اذلي ًوؼة دورا" ىاما" يف اﶈافظة ػىل سﻻمة امفم. املرىض اذلٍن ؼًاهون من هلص يف اﻷفراز انوؼايب حكون دلهيم مشبلك يف اﻷلك، امخحدث، و امبوع و ًطبحون غرضة مﻷههتاابت يف اﻷغش َة ااطَة و امنخر املندرش يف اﻷس نان. ًوخد ثﻻثة أزواج من امغدد انوؼاتَة ام ئرُسة – امغدة امنكفِة، امغدة حتت امفكِة، و حتت انوساهَة، موضؼيا ٍكون خارج امخجوًف امفموي، يف حمفظة و ميخد هظاهما املنَوي مَفرغ افرازاهتا. وًوخد أًضا" امؼدًد من امغدد انوؼاتَة امطغرية ، انوساهَة، اتحنكِة، ادلىوزيًة، انوساهَة احلنكِة وما كبل امرخوًة، ٍكون موضؼيا مﻷسفل و مضن امغشاء ااطي، غري حماطة مبحفظة مع هجاز كنَوي كطري. افرازات امغدد انوؼاتَة ام ئرُسة مُست مدشاهبة. امغدة امفكِة ثفرز مؼاب مطيل غين ابﻷمِﻻز، وامغدة حتت امفكِة ثنذج مؼاب غين اباط، أما امغدة حتت انوساهَة ثنذج مؼااب" مزخا". ثبؼا" ميذه اﻷخذﻻفات، انوؼاب املوحود يق امفم ٌشار امَو مكزجي. ح كرَة املزجي انوؼايب مُس ثس َطا" واملادة اﻷضافِة اموػة من لك املفرزات انوؼاتَة، اكمؼدًد من امربوثُنات ثنذلل ثرسػة وثوخطق هبدروكس َل اﻷتُذاًت مﻷس نان و سطوح ااطَة امفموًة. ثبدأ أمراض امغدد انوؼاتَة ػادة تخغريات اندرة يف املفرزات و ام كرتَة، وىذه امخغريات ثؤثر اثهواي" من خﻻل جشلك انووحية اجلرثومِة و املوح، اميت تدورىا ثؤدي اىل خنور مذفش َة وأمراض وس َج دامعة. ىذه اﻷمراض ميكن أن ثطبح شدًدة تؼد املؼاجلة امشؼاغَة ﻷن امؼدًد من احلاﻻت اجليازًة )مثل امسكري، امخوَف اهكُيس( ثؤثر يف اجلراين انوؼايب، و ٌش خيك املرض من حفاف يف امفم.
  • Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency

    Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency

    Practice parameter Practice parameter for the diagnosis and management of primary immunodeficiency Francisco A. Bonilla, MD, PhD, David A. Khan, MD, Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD, David I. Bernstein, MD, Joann Blessing-Moore, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Chief Editor: Francisco A. Bonilla, MD, PhD Co-Editor: David A. Khan, MD Members of the Joint Task Force on Practice Parameters: David I. Bernstein, MD, Joann Blessing-Moore, MD, David Khan, MD, David Lang, MD, Richard A. Nicklas, MD, John Oppenheimer, MD, Jay M. Portnoy, MD, Christopher R. Randolph, MD, Diane Schuller, MD, Sheldon L. Spector, MD, Stephen Tilles, MD, Dana Wallace, MD Primary Immunodeficiency Workgroup: Chairman: Francisco A. Bonilla, MD, PhD Members: Zuhair K. Ballas, MD, Javier Chinen, MD, PhD, Michael M. Frank, MD, Joyce T. Hsu, MD, Michael Keller, MD, Lisa J. Kobrynski, MD, Hirsh D. Komarow, MD, Bruce Mazer, MD, Robert P. Nelson, Jr, MD, Jordan S. Orange, MD, PhD, John M. Routes, MD, William T. Shearer, MD, PhD, Ricardo U. Sorensen, MD, James W. Verbsky, MD, PhD GlaxoSmithKline, Merck, and Aerocrine; has received payment for lectures from Genentech/ These parameters were developed by the Joint Task Force on Practice Parameters, representing Novartis, GlaxoSmithKline, and Merck; and has received research support from Genentech/ the American Academy of Allergy, Asthma & Immunology; the American College of Novartis and Merck.
  • Classification of Salivary Gland Disorders

    Classification of Salivary Gland Disorders

    Salivary Gland Diseases and Disorders Dr. Mahmoud E. Khalifa Prof of OMFS Lecture ILOs At the end of this chapter you should be able to: 1. Distinguish the clinical features of infections of the salivary glands from those in other structures 2. Differentiate on clinical grounds between infection, obstruction, benign and malignant neoplasms of the salivary glands 3. Plan and evaluate the results of the investigation of disorders of the salivary glands 4. List the important/relevant information to be elicited from patients with salivary gland disorders 5. Select cases which require referral for a specialist opinion 6. Describe the causes of a dry mouth and be able to distinguish between organic and functional causes. Anatomy Major glands Minor glands 3 pairs Situated mostly 800 to 1000 in the oral cavity Parotid Submandibular The majority atAlso found in the the junction of pharynx, larynx, the hard and soft trachea, and palates sinuses sublingual Functions These glands function to produce saliva, which serves as Lubricant for speech & swallowing Assists taste Immunologic (antibacterial) Digestive Cleansing properties Based on the type of secretion, the salivary glands may be grouped as: (i) Serous, (ii) Mucous and (iii) Mixed. Parotid gland secretion is serous in nature. The sublingual gland secretes mixed, but predominantly mucous. The submandibular gland secretion is also mixed, but is predominantly serous. The minor glands secrete mucous saliva. Parotid Gland The parotid gland is the largest salivary gland, the secretion of which is serous in nature. It is pyramidal in shape; The base located superficial and apex medially The base is triangular in shape its apex is towards the angle of the mandible, the base at the external acoustic meatus The parotid duct (Stenson‘s duct) Emerges at the anterior part of the gland.
  • Chapter 11. Non-Neoplastic Diseases of Salivary Glands

    Chapter 11. Non-Neoplastic Diseases of Salivary Glands

    Surgical pathology of the mouth and jaws R. A. Cawson, J. D. Langdon, J. W. Eveson 11. Non-neoplastic diseases of salivary glands Investigation Investigations will be discussed in relation to specific disorders and those more appropriate to neoplasms are discussed in the following chapter. However, it must be emphasized that chronic inflammatory swellings of the major salivary glands, in particular, sometimes cannot be distinguished from neoplasms clinically. Nevertheless, biopsy of the parotid glands is contraindicated because of the frequency of pleomorphic adenomas which can be seeded into the surrounding tissues to produce multiple recurrences. There are also the risks of damaing branches of the facial nerve or of producing a parotid fistula. For imaging techniques, see Chapters 1 and 12. Developmental disorders Aplasia/agenesis. Complete absence of one or more salivary glands is very rare, but occasionally the parotid glands are absent. Absence of all major salivary glands is even more rare. Duct atresia. This is also rare, but usually affects the submandibular duct in the floor of the mouth. Absence of the duct results in retention cysts of the submandibular and sublingual glands. Salivary gland hypoplasia. This can be a feature of the Melkersson-Rosenthal syndrome. The hypoplasia possibly may be secondary to atrophy of parasympathetic nerves thought to be implicated in this syndrome. Congenital salivary fistulae. These are sometimes seen in association with branchial clefts. Aberrant salivary tissue. This is common in the cervical lymph nodes (where it should not be mistaken for a metastasis) and may be found in the middle ear cleft. Stafne's bone cavity is another example.
  • The Investigation of Major Salivary Gland Agenesis: a Case Report

    The Investigation of Major Salivary Gland Agenesis: a Case Report

    Oral Pathology The investigation of major salivary gland agenesis: A case report T.A. Hodgson FDS, RCS, MRCP(UK) R. Shah FDS, RCS S.R. Porter MD, PhD, FDS, RCS, FDS, RCSE Dr. Hodgson is a specialist registrar and professor, and Dr. Porter is a consultant and head of department, Department of Oral Medicine; Dr. Shah is senior house officer, Department of Pediatric Dentistry , Eastman Dental Institute for Oral Health Care Sciences, University College London. Correspond with Dr. Hodgson at [email protected] Abstract Salivary gland agenesis is an extremely uncommon congenital The present report details a child with rampant dental car- anomaly, which may cause a profound xerostomia in children. The ies secondary to xerostomia. Despite having oral disease for oral sequelae includes dental caries, candidosis, and ascending many years, the congenital absence of all the salivary glands sialadenitits. failed to be established until late adolescence, and, therefore, The present report details a child with rampant dental caries appropriate replacement therapy was not instituted, until this secondary to xerostomia. Despite having oral disease for many years, time, to prevent further oral disease. the congenital absence of all the salivary glands failed to be estab- lished until early adulthood. Case report The appropriate investigation and management of the In 1988, a 41/2-year-old Caucasian female was referred to the xerostomic child allows a definitive diagnosis to be made and at- Department of Pediatric Dentistry of the Eastman Dental In- tention focused on the prevention and treatment of resultant oral stitute for Oral Health Care Sciences for the extraction of disease.
  • Treatments for Ankyloglossia and Ankyloglossia with Concomitant Lip-Tie Comparative Effectiveness Review Number 149

    Treatments for Ankyloglossia and Ankyloglossia with Concomitant Lip-Tie Comparative Effectiveness Review Number 149

    Comparative Effectiveness Review Number 149 Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie Comparative Effectiveness Review Number 149 Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2012-00009-I Prepared by: Vanderbilt Evidence-based Practice Center Nashville, TN Investigators: David O. Francis, M.D., M.S. Sivakumar Chinnadurai, M.D., M.P.H. Anna Morad, M.D. Richard A. Epstein, Ph.D., M.P.H. Sahar Kohanim, M.D. Shanthi Krishnaswami, M.B.B.S., M.P.H. Nila A. Sathe, M.A., M.L.I.S. Melissa L. McPheeters, Ph.D., M.P.H. AHRQ Publication No. 15-EHC011-EF May 2015 This report is based on research conducted by the Vanderbilt Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2012-00009-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment.
  • Plastic Surgery Essentials for Students Handbook to All Third Year Medical Students Concerned with the Effect of the Outcome on the Entire Patient

    Plastic Surgery Essentials for Students Handbook to All Third Year Medical Students Concerned with the Effect of the Outcome on the Entire Patient

    AMERICAN SOCIETY OF PLASTIC SURGEONS YOUNG PLASTIC SURGEONS STEERING COMMITTEE Lynn Jeffers, MD, Chair C. Bob Basu, MD, Vice Chair Eighth Edition 2012 Essentials for Students Workgroup Lynn Jeffers, MD Adam Ravin, MD Sami Khan, MD Chad Tattini, MD Patrick Garvey, MD Hatem Abou-Sayed, MD Raman Mahabir, MD Alexander Spiess, MD Howard Wang, MD Robert Whitfield, MD Andrew Chen, MD Anureet Bajaj, MD Chris Zochowski, MD UNDERGRADUATE EDUCATION COMMITTEE OF THE PLASTIC SURGERY EDUCATIONAL FOUNDATION First Edition 1979 Ruedi P. Gingrass, MD, Chairman Martin C. Robson, MD Lewis W.Thompson, MD John E.Woods, MD Elvin G. Zook, MD Copyright © 2012 by the American Society of Plastic Surgeons 444 East Algonquin Road Arlington Heights, IL 60005 All rights reserved. Printed in the United States of America ISBN 978-0-9859672-0-8 i INTRODUCTION PREFACE This book has been written primarily for medical students, with constant attention to the thought, A CAREER IN PLASTIC SURGERY “Is this something a student should know when he or she finishes medical school?” It is not designed to be a comprehensive text, but rather an outline that can be read in the limited time Originally derived from the Greek “plastikos” meaning to mold and reshape, plastic surgery is a available in a burgeoning curriculum. It is designed to be read from beginning to end. Plastic specialty which adapts surgical principles and thought processes to the unique needs of each surgery had its beginning thousands of years ago, when clever surgeons in India reconstructed individual patient by remolding, reshaping and manipulating bone, cartilage and all soft tissues.
  • Clinical and Molecular Investigation of Rare

    Clinical and Molecular Investigation of Rare

    CLINICAL AND MOLECULAR INVESTIGATION OF RARE CONGENITAL DEFECTS OF THE PALATE RIMANTE SESELGYTE A thesis submitted for the degree of Doctor of Philosophy to University College London August 2019 page Title 1 DECLARATION I, Rimante Seselgyte, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis. Signed……………………….. Declaration 3 ABSTRACT Cleft palate (CP) affects around 1/1500 live births and, along with cleft lip, is one of the most common forms of birth defect. The studies presented here focus on unusual defects of the palate, especially to understand better the rarely reported but surprisingly common condition called submucous cleft palate (SMCP). The frequency and consequences of SMCP from a surgical perspective were first investigated based on the caseload of the North Thames Cleft Service at Great Ormond Street Hospital and St Andrew's Centre, Broomfield Hospital, Mid Essex Hospitals Trust. It was previously reported that up to 80% of individuals with unrepaired SMCP experience speech difficulties as a consequence of velopharyngeal insufficiency (VPI). Attempted repair of the palatal defect can sometimes give poor results, so controversies still exist about the correct choice of surgical technique to use. Over 23 years, 222 patients at The North Thames Cleft Service underwent operations to manage SMCP. Nearly half of them (42.8%) were diagnosed with 22q11.2 deletion syndrome (22q11.2 DS). The first operation was palate repair, with an exception of one case, followed by a second surgical intervention required in approximately half of the patients.
  • Dental Manifestations in Bariatric Patients – Review of Literature

    Dental Manifestations in Bariatric Patients – Review of Literature

    www.scielo.br/jaos Dental manifestations in bariatric patients – review of literature Carolina Silveira BARBOSA1, Gabriel Salles BARBÉRIO1, Vinicius Rizzo MARQUES1, Vitor de Oliveira BALDO1, Marília Afonso Rabelo BUZALAF2, Ana Carolina MAGALHÃES3 1- Undergraduate student, Bauru School of Dentistry, University of São Paulo. 2- DDS, MSc, PhD, Full Professor, Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo. 3- DDS, MSc, PhD, Assistant Professor, Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo. Corresponding address: Ana Carolina Magalhães - Faculdade de Odontologia de Bauru - Universidade de São Paulo - Departamento de Ciências Biológicas - Al. Octávio Pinheiro Brisolla, 9-75 Bauru-SP 17012-901 (Brazil) - Phone: + 55 14 32358246 Fax: + 55 14 32343164 - e-mail: [email protected] Received: August 19, 2009 - Accepted: February 19, 2010 ABSTRACT he rate of bariatric surgery has significantly risen in the past decade as an increasing Tprevalence of extreme obesity can be observed. Although bariatric surgery is an effective therapeutic modality for extreme obesity, it is associated with risk factors affecting also oral health. Based on an overview of the current literature, this paper presents a summary of dental manifestations in bariatric patients. Bariatric surgeries are associated with an increased risk for gastro-esophageal reflux which in turn might account for the higher amount of carious and erosive lesions observed in bariatric patients. As a result, also dentin hypersensitivity might be observed more frequently. The current data indicate that recommended postsurgical meal patterns and gastric reflux might increase the risk for dental lesions, particularly in the presence of other risk factors, such as consumption of sweet-tasting foods and acidic beverages.
  • Pharmacotherapy of Salivary Gland Disorders, Fungal Infections and AIDS. SALIVARY GLAND DISORDERS

    Pharmacotherapy of Salivary Gland Disorders, Fungal Infections and AIDS. SALIVARY GLAND DISORDERS

    Pharmacotherapy of salivary gland disorders, fungal infections and AIDS. SALIVARY GLAND DISORDERS 2 SALIVA physiological exudation of three pairs of salivary glands: parotid submandibular sublingual secreted reflexively composed of the mucous and serous components normal secretion of saliva: at rest (non stimulated) – 0,3 – 0,4 ml/min stimulated (by chewing paraffin cubes) 1 – 2 ml/min 3 DISORDERS SECRETION OF SALIVA Increase the secretion of Reduce the secretion of saliva saliva (without mucosal atrophy) (with mucosal atrophy) Sialoses 4 SALIVARY DYSFUNCTION CLASSIFICATION Pseudo xerostomia (xerostomia spuria) is regarded as a product of vegetative neurosis - no changes in the salivary glands, accompanied by a strong burning sensation of tongue 5 SALIVARY DYSFUNCTION CLASSIFICATION True xerostomia type I (xerostomia vera) can be caused by: neurovegetative system disorders (stress, severe mental experiences, medications) certain infectious diseases (eg. inflammation of the parotid glands) lithiasis of salivary glands diabetes, collagenoses, thyroid diseases vomiting, diarrhea, loss of blood 6 SALIVARY DYSFUNCTION CLASSIFICATION True xerostomia type II is due to degenerative processes affecting salivary glands: Sjögren’s syndrome Mikulicz disease irradiation congenital salivary gland aplasia 7 REDUCE THE SECRETION OF SALIVA Drugs reducing the secretion of saliva: antihypertensive drugs anticholinergic drugs antidepressants sedatives appetite suppressants antihistamines bronchodilators cytotoxic drugs 8 TREATMENT
  • Salivary Gland Pathology 25.Pdf

    Salivary Gland Pathology 25.Pdf

    k Index 461 Mechanoreceptors, 15 patient history, 284 Melanoma pleomorphic adenoma, 286–290 desmoplastic subtype, 63 polymorphous low-grade adenocarcinoma, 174–175, 306, histopathology, 381 309, 312 lower lip, 380–381 primary lymphomas, 368 metastases, 62–63, 189 radiation therapy, 328 nodular, 379 sites of, 285 Merkel cell tumors, metastases, 62, 63, 375 staging, 193–196 Mesenchymal-epithelial transition (MET), 214 Mixed tumor. See Pleomorphic adenoma(s) Mesenchymal neoplasms, 188 Modified Blair incision, 238, 239 Mesenchymal salivary gland tumors Monomorphic adenoma, 167–169, 290 lymphatic malformations, 398, 400 Monomorphic clear cell tumor, 182 neural tumors, 398, 401, 402 Motion artifacts, 21–22 vascular tumors, 397–398, 397–399 Mouth Messenger ribonucleic acid (mRNA), 208, 209, 209 dry, 141 Metal deposits, brain, 24 ranula, 98, 99, 100 Metallic implants, 21, 22 MRI. See Magnetic resonance imaging (MRI) Metalloproteinases, 142 MRS. See Magnetic resonance spectroscopy (MRS) Metastases, 189 Mucocele, 97, 99, 114, 412 diagnostic imaging, 62–64, 63 Mucoepidermoid carcinoma (MEC), 170–172, 214, 389, distant. See Distant metastases 390, 396, 404 regional. See Regional metastases ADC values, 27 skip, 270 biomarkers, 190, 263 Metastasizing mixed tumor, 182, 289 buccal mucosa, 294 Metastasizing pleomorphic adenoma, 287 children, 297 Methicillin resistant S. aureus (MRSA), acute bacterial clear cell variant, 383 parotitis, 75, 78, 96 diagnostic imaging, 56, 57 k Microliths, 439 fixed to mandible, 277 k Middle ear, aberrant glands, 438 grading,